Cicinelli Ettore, Tinelli Raffaele, Colafiglio Giuseppe, Saliani Nicola
Department of Obstetrics and Gynecology, University of Bari Medical School, Bari, Italy.
J Minim Invasive Gynecol. 2009 Jul-Aug;16(4):422-6. doi: 10.1016/j.jmig.2009.03.011.
OBJECTIVE: To compare outcomes in patients with symptomatic uterine myomas who underwent laparoscopic (LPS) or minilaparotomic (MLPT) myomectomy. DESIGN: Prospective randomized study (Canadian Task Force classification II-2). SETTING: University hospital. PATIENTS: Eighty patients with no more than 3 uterine myomas of maximal diameter of 7 cm. INTERVENTION: Either LPS or MLPT myomectomy. MEASUREMENTS AND MAIN RESULTS: Mean blood loss, mean duration of postoperative ileus, and mean decrease in hemoglobin were significantly lower in the LPS compared with the MLPT group (p < .001). Mean operative time was not significantly longer in the LPS group compared with the MLPT group. Duration of hospitalization was significantly shorter in the LPS compared with the MLPT group (p < .001). No intraoperative complications were observed during MLPT. In 1 patient, conversion from LPS to MLPT was necessary because of difficulty in reconstructing the uterine wall. CONCLUSION: Laparoscopic myomectomy is a suitable alternative to MLPT in women with 1 to 3 myomas. However, preoperative careful evaluation of the size and sites of the myomas is necessary to avert conversion and prevent complications.
目的:比较接受腹腔镜(LPS)或小切口开腹(MLPT)子宫肌瘤剔除术的有症状子宫肌瘤患者的治疗结果。 设计:前瞻性随机研究(加拿大工作组分类II-2)。 地点:大学医院。 患者:80例患者,子宫肌瘤不超过3个,最大直径为7厘米。 干预措施:LPS或MLPT子宫肌瘤剔除术。 测量指标及主要结果:与MLPT组相比,LPS组的平均失血量、术后平均肠梗阻持续时间和平均血红蛋白下降幅度显著更低(p < .001)。与MLPT组相比,LPS组的平均手术时间并无显著延长。与MLPT组相比,LPS组的住院时间显著更短(p < .001)。MLPT术中未观察到并发症。有1例患者因子宫壁重建困难,需由LPS转为MLPT。 结论:对于有1至3个肌瘤的女性,腹腔镜子宫肌瘤剔除术是MLPT的合适替代方法。然而,术前需仔细评估肌瘤的大小和位置,以避免中转手术并预防并发症。
J Minim Invasive Gynecol. 2009
J Minim Invasive Gynecol. 2008
J Minim Invasive Gynecol. 2006
J Minim Invasive Gynecol. 2005
J Minim Invasive Gynecol. 2010-6-23
Robot Surg. 2017-1-23
GMS Interdiscip Plast Reconstr Surg DGPW. 2012-1-9
Cochrane Database Syst Rev. 2014-10-21